(Q38599299)

English

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.

scientific article published on 25 August 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Robert P Giugliano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Gaetano M. De Ferrari

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jose Lopez-Miranda

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

12

object named as

Brian R Ott

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Terje R Pedersen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jeong-Gun Park

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Zbigniew A Gaciong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Richard Ceska

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Kalman Toth

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ioanna Gouni-Berthold

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

François Schiele

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

François Mach

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Estella Kanevsky

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Armando Lira Pineda

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ransi Somaratne

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Scott M Wasserman

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Anthony C Keech

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Peter S Sever

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Marc S Sabatine

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

FOURIER Investigators

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

language of work or name

0 references

publication date

28 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

390

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

10106

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1962-1971

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive Function in a Randomized Trial of Evolocumab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin bac

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The measurement of everyday cognition (ECog): scale development and psychometric properties

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A simulation study of the number of events per variable in logistic regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

No adjustments are needed for multiple comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An assessment by the Statin Diabetes Safety Task Force: 2014 update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An assessment by the Statin Liver Safety Task Force: 2014 update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An assessment by the Statin Muscle Safety Task Force: 2014 update.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932290-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(17)32290-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

release_y5z7x5rno5bb3p3dolqug2xbqe

1 reference

https://api.fatcat.wiki/v0/release/y5z7x5rno5bb3p3dolqug2xbqe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28859947%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38599299&oldid=1844568122"